DK1173436T3 - Thiazolidindionderivat og anvendelse deraf som antidiabetikum - Google Patents

Thiazolidindionderivat og anvendelse deraf som antidiabetikum

Info

Publication number
DK1173436T3
DK1173436T3 DK00920893T DK00920893T DK1173436T3 DK 1173436 T3 DK1173436 T3 DK 1173436T3 DK 00920893 T DK00920893 T DK 00920893T DK 00920893 T DK00920893 T DK 00920893T DK 1173436 T3 DK1173436 T3 DK 1173436T3
Authority
DK
Denmark
Prior art keywords
diabetic
thiazolidinedione derivative
thiazolidinedione
derivative
Prior art date
Application number
DK00920893T
Other languages
Danish (da)
English (en)
Inventor
Paul David James Smit Blackler
Robert Gordon Giles
Michael John Sasse
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of DK1173436T3 publication Critical patent/DK1173436T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK00920893T 1999-04-20 2000-04-19 Thiazolidindionderivat og anvendelse deraf som antidiabetikum DK1173436T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9909041.7A GB9909041D0 (en) 1999-04-20 1999-04-20 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
DK1173436T3 true DK1173436T3 (da) 2004-09-27

Family

ID=10851901

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00920893T DK1173436T3 (da) 1999-04-20 2000-04-19 Thiazolidindionderivat og anvendelse deraf som antidiabetikum

Country Status (42)

Country Link
EP (2) EP1411055A1 (fr)
JP (2) JP4283449B2 (fr)
KR (1) KR100601244B1 (fr)
CN (2) CN1327447A (fr)
AP (1) AP1562A (fr)
AR (2) AR023562A1 (fr)
AT (1) ATE268770T1 (fr)
AU (2) AU4130900A (fr)
BG (1) BG65864B1 (fr)
BR (1) BR0009897A (fr)
CA (1) CA2382036A1 (fr)
CO (1) CO5170422A1 (fr)
CZ (1) CZ300653B6 (fr)
DE (1) DE60011419T2 (fr)
DK (1) DK1173436T3 (fr)
DZ (1) DZ3162A1 (fr)
EA (1) EA004232B1 (fr)
EG (1) EG24063A (fr)
ES (1) ES2218146T3 (fr)
GB (1) GB9909041D0 (fr)
HK (1) HK1045151B (fr)
HR (1) HRP20010770B1 (fr)
HU (1) HUP0200865A3 (fr)
IL (1) IL146078A0 (fr)
MA (1) MA26783A1 (fr)
MX (1) MXPA01010696A (fr)
MY (1) MY126034A (fr)
NO (1) NO320609B1 (fr)
NZ (1) NZ515166A (fr)
OA (1) OA11866A (fr)
PE (1) PE20010050A1 (fr)
PL (1) PL351135A1 (fr)
PT (1) PT1173436E (fr)
RS (1) RS50136B (fr)
SI (1) SI1173436T1 (fr)
SK (1) SK284991B6 (fr)
TR (1) TR200103040T2 (fr)
TW (1) TWI277616B (fr)
UA (1) UA71615C2 (fr)
UY (1) UY26112A1 (fr)
WO (1) WO2000063205A2 (fr)
ZA (1) ZA200108720B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9909041D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical
GB0006133D0 (en) 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical
GB0014005D0 (en) * 2000-06-08 2000-08-02 Smithkline Beecham Plc Novel pharmaceutical
DE60217168T2 (de) * 2001-11-21 2007-10-04 Smithkline Beecham Plc, Brentford 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dion-benzolsulfonat; prozess zu seiner herstellung; polymorphe i, ii und iii davon; und seine verwendung als pharmazeutischer wirkstoff
GB0129872D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
CZ296468B6 (cs) * 2004-06-10 2006-03-15 Zentiva, A. S. Sul kyseliny fosforecné s 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidin-2,4-dionema zpusob její prípravy
CZ2004844A3 (cs) * 2004-07-27 2006-03-15 Zentiva, A. S Sul kyseliny stavelové s 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidin-2,4-dionu azpusob její prípravy a její pouzití
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
EP1842850A1 (fr) * 2006-03-23 2007-10-10 Sandoz AG Rosiglitazone hydrochlorid hemihydrat

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3856378T2 (de) * 1987-09-04 2000-05-11 Beecham Group Plc Substituierte Thiazolidindionderivate
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9726563D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726566D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726568D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9909041D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
CN1327447A (zh) 2001-12-19
NZ515166A (en) 2004-02-27
AR023562A1 (es) 2002-09-04
EP1411055A1 (fr) 2004-04-21
GB9909041D0 (en) 1999-06-16
RS50136B (sr) 2009-03-25
AU2755202A (en) 2002-05-16
DZ3162A1 (fr) 2000-10-26
SK284991B6 (sk) 2006-04-06
WO2000063205A2 (fr) 2000-10-26
DE60011419T2 (de) 2005-06-16
HRP20010770B1 (en) 2005-06-30
KR100601244B1 (ko) 2006-07-19
HUP0200865A2 (en) 2002-08-28
PE20010050A1 (es) 2001-03-10
SK14902001A3 (sk) 2002-02-05
WO2000063205A3 (fr) 2001-01-25
HK1045151A1 (en) 2002-11-15
KR20010110791A (ko) 2001-12-13
NO20015104L (no) 2001-12-19
BR0009897A (pt) 2002-04-16
BG106112A (bg) 2002-05-31
HUP0200865A3 (en) 2005-04-28
MA26783A1 (fr) 2004-12-20
PT1173436E (pt) 2004-10-29
AP1562A (en) 2006-02-01
AU765911B2 (en) 2003-10-02
YU81501A (sh) 2004-07-15
NO320609B1 (no) 2005-12-27
CO5170422A1 (es) 2002-06-27
CZ300653B6 (cs) 2009-07-08
EG24063A (en) 2008-05-08
DE60011419D1 (de) 2004-07-15
TR200103040T2 (tr) 2002-04-22
EP1173436B1 (fr) 2004-06-09
OA11866A (en) 2006-03-02
EP1173436A2 (fr) 2002-01-23
JP2009143954A (ja) 2009-07-02
JP4283449B2 (ja) 2009-06-24
JP2002542242A (ja) 2002-12-10
EA004232B1 (ru) 2004-02-26
TWI277616B (en) 2007-04-01
CA2382036A1 (fr) 2000-10-26
MXPA01010696A (es) 2002-06-04
MY126034A (en) 2006-09-29
HK1045151B (zh) 2005-03-18
SI1173436T1 (en) 2004-12-31
ES2218146T3 (es) 2004-11-16
UA71615C2 (uk) 2004-12-15
IL146078A0 (en) 2002-07-25
HRP20010770A2 (en) 2002-10-31
CN101134756A (zh) 2008-03-05
ATE268770T1 (de) 2004-06-15
EA200101101A1 (ru) 2002-04-25
AR023566A1 (es) 2002-09-04
AP2001002331A0 (en) 2000-04-19
ZA200108720B (en) 2002-11-28
AU4130900A (en) 2000-11-02
UY26112A1 (es) 2000-12-29
PL351135A1 (en) 2003-03-24
NO20015104D0 (no) 2001-10-19
BG65864B1 (bg) 2010-03-31
CZ20013759A3 (cs) 2002-05-15

Similar Documents

Publication Publication Date Title
IS6385A (is) Ný notkun og nýjar N-asabísýkló-amíð afleiður
DK1216247T3 (da) Imidazoimidazoler og triazoler som anti-inflammatoriske midler
NO20025978D0 (no) Benzotiazol-derivater
DK1329456T3 (da) Glucopyranosyloxybenzylbenzenderivater og medicinske sammensætninger indeholdende samme
NO20050077L (no) Substituerte heterocykliske derivater som er anvendelige som antidiabetes- og antiovervektsmidler
NO20022086L (no) Antidiabetisk formulering og fremgangsmåte
NO20020683L (no) Arylmetyl karbonylamino tiazolderivater og deres anvendelse som antitumormidler
NO20032842L (no) Karbazolderivater og deres anvendelse som neuropeptid Y5- reseptor-ligander
ATE391505T1 (de) Benzothiazole derivative
NO20021253L (no) Kinolylpropylpiperidinderivater og deres anvendelse som antibakterielle midler
DK1244641T3 (da) Thiazolylamid-derivater
DK1173434T3 (da) Thiazolidindionderivat og dets anvendelse som antidiabetisk middel
IS2841B (is) Samstæða hluta og lyfjasamsetningar
NO20001905L (no) (Poly)tiaalkynforbindelser og deres derivater, preparater omfattende disse og deres anvendelse
NO20020155D0 (no) Aminotiazolderivater og deres anvendelse som CRF reseptorligander
IL146115A0 (en) Thiazolidinedione derivative and its use as antidiabetic
DK1173436T3 (da) Thiazolidindionderivat og anvendelse deraf som antidiabetikum
DK1231211T3 (da) Thiazolidindion-derivater som antidiabetika
DE60032898D1 (de) Arylthiazolidindion- und aryloxazolidinderivate
NO20025968D0 (no) Pyridin-2-yl-aminoalkylkarbonylglycyl-<beta>-alanin og derivater derav
DE60212694D1 (de) Benzothiazolderivaten
DK1173437T3 (da) Thiazolidinindionderivat og dets anvendelse som antidiabetisk middel
DK1392670T3 (da) Substituerede C-furan-2-yl-methylamin- og C-thiophen-2-yl-methylamin-derivater
NO20035652D0 (no) Tiaziner og tiazoler som materialbeskyttelsesmidler
NO20031434D0 (no) Tiazolidindionderivater og deres anvendelse som antidiabetiske midler